Global Pharmacovigilance OutsourcingMarket Insights Covering Revenue Trends And Future Growth Outlook

 The Business Research Company’s 2026 market reports incorporate enhanced features, including market attractiveness scoring and analysis, total addressable market evaluation, a company scoring matrix, an interactive Excel data dashboard, refined supply chain analysis, insights on emerging startups, and overviews of key products, all aimed at improving the depth, usability, and strategic relevance of the insights delivered.

 
 What Will Be The Estimated Market Value Of The Pharmacovigilance Outsourcing Market By The End Of The Forecast Timeline?
 The pharmacovigilance outsourcing market size has grown rapidly in recent years. It will grow from $7.24 billion in 2025 to $8.51 billion in 2026 at a compound annual growth rate (CAGR) of 17.6%. The growth in the historic period can be attributed to rising number of new drug approvals, increasing pharmacovigilance awareness among pharma companies, lack of in-house pv expertise, growing regulatory scrutiny, expansion of global clinical trials.
 
 The pharmacovigilance outsourcing market size is expected to see rapid growth in the next few years. It will grow to $16.09 billion in 2030 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to integration of ai and data analytics in pv processes, increasing outsourcing to cro and bpo providers, adoption of cloud-based pharmacovigilance platforms, expansion of global safety reporting requirements, growing investment in it infrastructure and technology support. Major trends in the forecast period include increasing adoption of outsourced pharmacovigilance services by pharma companies, rising regulatory compliance requirements and reporting standards, growth in automation of adr capture and case processing, expansion of knowledge management and data integration solutions, enhanced focus on risk management and quality assurance services.
 
 Download Your Free Report Sample:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=19651&type=smp
 
 Which Factors Are Expected To Fuel The Pharmacovigilance Outsourcing Market In The Coming Years?
 The rising number of clinical trials is expected to propel the growth of the pharmacovigilance outsourcing market going forward. Clinical trials are research studies conducted to evaluate the safety, efficacy, and potential side effects of new treatments, drugs, or medical devices. Clinical trials are rising due to several reasons, including the growing focus on precision medicine, the rising incidence of chronic diseases, regulatory support, and the globalization of research. Pharmacovigilance outsourcing in clinical trials enhances drug safety monitoring by leveraging specialized expertise and resources to ensure compliance with regulatory requirements and improve efficiency. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade association, the number of industry clinical trials initiated in the UK increased to 426 in 2023, from 411 in 2022. Therefore, the rising number of clinical trials is driving the growth of the pharmacovigilance outsourcing market.
 
 Which Firms Are Leading Innovation In The Pharmacovigilance Outsourcing Market?
 The pharmacovigilance outsourcing market covered in this report is segmented — 
 
 1) By Type: Adverse Drug Reaction Capture (ADR), Case Processing, Reporting And Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, Enabling Architecture
 2) By Service Provider: Contract Research Organization, Business Processing Outsourcing
 3) By End User: Pharmaceutical Industry, Research Organization, Other End Users
 
 Subsegments:
 1) By Adverse Drug Reaction Capture (ADR): Automated ADR Reporting Tools, Manual ADR Reporting Solutions, ADR Data Mining Software 
 2) By Case Processing: Case Intake and Triage Services, Medical Review and Evaluation Services, Data Entry and Management Services 
 3) By Reporting And Submission: Regulatory Reporting Services, Submission to Health Authorities, Compliance Tracking Services 
 4) By Report Publishing: Clinical Study Report Publishing, Safety Update Report Publishing, Final Study Report Publishing 
 5) By Quality Check: Quality Assurance Services, Audit and Inspection Services, Compliance Monitoring Services 
 6) By Risk Management: Risk Assessment Services, Risk Minimization Strategies, Benefit-Risk Evaluation Services 
 7) By Knowledge Management: Data Management Solutions, Pharmacovigilance Database Management, Knowledge Sharing Platforms 
 8) By Enabling Architecture: IT Infrastructure Solutions, Data Integration Services, Technology Platform Support 
 
 What Positive Trends Are Supporting Growth In The Pharmacovigilance Outsourcing Market?
 Major companies operating in the pharmacovigilance outsourcing market are focusing on developing innovative solutions, such as a cloud-based data lake platform, to optimize pharmacovigilance case processing and safety data management processes for enhancing clinical research registries and ensuring compliance with regulatory requirements. A cloud-based data lake platform is a centralized repository that allows you to store and manage large amounts of raw data in its native format until it’s needed. For instance, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and laboratory equipment company, launched CorEvidence, designed to enhance clinical research registries. It is designed to streamline pharmacovigilance case processing by handling multiple data sources and optimizing the coding, classification, and reporting of adverse events. Its significance lies in providing scalable, compliant, and auditable safety management, enhancing CorEvitas clinical research registries, and supporting long-term post-authorization safety studies across multiple therapeutic areas.
 
 What Are The Key Segments Within The Pharmacovigilance Outsourcing Market?
 The pharmacovigilance outsourcing market covered in this report is segmented — 
 
 1) By Type: Adverse Drug Reaction Capture (ADR), Case Processing, Reporting And Submission, Report Publishing, Quality Check, Risk Management, Knowledge Management, Enabling Architecture
 2) By Service Provider: Contract Research Organization, Business Processing Outsourcing
 3) By End User: Pharmaceutical Industry, Research Organization, Other End Users
 
 Subsegments:
 1) By Adverse Drug Reaction Capture (ADR): Automated ADR Reporting Tools, Manual ADR Reporting Solutions, ADR Data Mining Software 
 2) By Case Processing: Case Intake and Triage Services, Medical Review and Evaluation Services, Data Entry and Management Services 
 3) By Reporting And Submission: Regulatory Reporting Services, Submission to Health Authorities, Compliance Tracking Services 
 4) By Report Publishing: Clinical Study Report Publishing, Safety Update Report Publishing, Final Study Report Publishing 
 5) By Quality Check: Quality Assurance Services, Audit and Inspection Services, Compliance Monitoring Services 
 6) By Risk Management: Risk Assessment Services, Risk Minimization Strategies, Benefit-Risk Evaluation Services 
 7) By Knowledge Management: Data Management Solutions, Pharmacovigilance Database Management, Knowledge Sharing Platforms 
 8) By Enabling Architecture: IT Infrastructure Solutions, Data Integration Services, Technology Platform Support 
 
 Explore the Complete Pharmacovigilance Outsourcing Market Report:
 https://www.thebusinessresearchcompany.com/report/pharmacovigilance-outsourcing-global-market-report
 
 Which Regions Are Likely To Dominate The Pharmacovigilance Outsourcing Market During The Forecast Period?
 https://www.thebusinessresearchcompany.com/report/pharmacovigilance-outsourcing-global-market-report
 
 #Contact Us:#
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: marketing@tbrc.info
 
 #Follow Us On:#
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company